Amarin Corp. Plc (AMRN)
11.37
-0.30
(-2.57%)
USD |
NASDAQ |
Nov 13, 16:00
11.37
0.00 (0.00%)
After-Hours: 19:50
Amarin Enterprise Value : -72.20M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | -72.20M |
| November 11, 2026 | -71.36M |
| November 10, 2026 | -70.52M |
| November 09, 2026 | -70.73M |
| November 06, 2026 | -73.47M |
| November 05, 2026 | -74.21M |
| November 04, 2026 | -59.98M |
| November 03, 2026 | -64.19M |
| November 02, 2026 | -62.51M |
| October 30, 2026 | -62.93M |
| October 29, 2026 | -49.75M |
| October 28, 2026 | -49.54M |
| October 27, 2026 | -66.30M |
| October 26, 2026 | -63.35M |
| October 23, 2026 | -69.67M |
| October 22, 2026 | -73.68M |
| October 21, 2026 | -75.58M |
| October 20, 2026 | -76.21M |
| October 19, 2026 | -75.16M |
| October 16, 2026 | -79.58M |
| October 15, 2026 | -74.31M |
| October 14, 2026 | -73.47M |
| October 13, 2026 | -74.10M |
| October 12, 2026 | -75.16M |
| October 09, 2026 | -64.62M |
| Date | Value |
|---|---|
| October 08, 2026 | -65.46M |
| October 07, 2026 | -64.83M |
| October 06, 2026 | -63.77M |
| October 05, 2026 | -63.35M |
| October 02, 2026 | -57.87M |
| October 01, 2026 | -50.07M |
| September 30, 2026 | -44.17M |
| September 29, 2026 | -33.63M |
| September 28, 2026 | -31.32M |
| September 25, 2026 | -32.37M |
| September 24, 2026 | -27.54M |
| September 23, 2026 | -21.44M |
| September 22, 2026 | -20.81M |
| September 21, 2026 | -26.49M |
| September 18, 2026 | -23.34M |
| September 17, 2026 | -18.29M |
| September 16, 2026 | -18.92M |
| September 15, 2026 | -17.03M |
| September 14, 2026 | -15.56M |
| September 11, 2026 | -19.76M |
| September 10, 2026 | -14.72M |
| September 09, 2026 | -7.373M |
| September 08, 2026 | -10.31M |
| September 04, 2026 | -23.34M |
| September 03, 2026 | -21.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 574.77M |
| Akari Therapeutics Plc | 4.334M |
| Cellectis SA | 71.36M |
| Alkermes Plc | 8.710B |
| Alnylam Pharmaceuticals, Inc. | 20.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.2449M |
| Revenue (Quarterly) | 39.53M |
| Total Expenses (Quarterly) | 39.29M |
| EPS Diluted (Quarterly) | 0.0114 |
| Gross Profit Margin (Quarterly) | 39.30% |
| Profit Margin (Quarterly) | 0.62% |
| Earnings Yield | -8.06% |
| Normalized Earnings Yield | -5.871 |